<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>16342</id><no>BIPAVE-001-NCT06635785</no><status>Open</status><title>Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors (BiPAVE-001)</title><secondary_protocol_no>BIPAVE-001</secondary_protocol_no><nct_id>NCT06635785</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>I/II</phase><disease_site>Other</disease_site><PI>Reuss, Joshua</PI><institution>Georgetown University Medical Center : Emmy Mckissick; Lombardi Comprehensive Cancer Center : Emmy Mckissick</institution><oncology_group>Phase I<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group><item><contact_id>16527</contact_id><item_description>Emmy Mckissick</item_description><js_safe_str>Emmy Mckissick</js_safe_str><email>mm5350@georgetown.edu</email><title>202 687 1104 </title></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>